Stocks at New 52-Week Highs — Financial View · Pharmaceutical Preparations
22 stocks match the Stocks at New 52-Week Highs screen. Stocks that have just made a fresh 52-week high — breakout stocks with strong momentum. Financial columns. Filtered to Pharmaceutical Preparations. Updated
Filters2
1–22 of 22
| JNJ | Johnson & Johnson | $670.6B | 1.9% | 10.5% | 24.8% | 17.2% | 1.09 | 0.44 | 67.9% | 22.0% | 21.5% | 278.28 | +1.04% | 216K |
| PFE | Pfizer | $164.2B | 6.0% | 2.2% | 5.1% | 3.0% | 1.27 | 0.71 | 73.2% | — | 6.8% | 28.81 | -0.76% | 1.8M |
| VRTX | Vertex Pharmaceuticals | $141.5B | — | 16.1% | 21.8% | 21.6% | 3.19 | 0.01 | 86.0% | 38.0% | 35.0% | 558.12 | +0.24% | 45K |
| REGN | Regeneron Pharmaceuticals | $87.2B | 0.4% | 10.4% | 13.7% | 12.8% | 3.34 | 0.06 | — | 24.7% | 27.9% | 843.50 | -1.02% | 28K |
| TVTX | Travere Therapeutics, Inc. | $6.3B | — | -5.4% | — | -61.6% | 4.05 | 1.88 | 98.6% | -6.8% | -7.4% | 66.50 | -1.06% | 68K |
| IDYA | Ideaya Biosciences, Inc. | $3.9B | — | -13.4% | -14.6% | -14.6% | 10.45 | 0.09 | — | -92.7% | -74.8% | 39.97 | -0.45% | 36K |
| OGN | Organon & Co. | $3.6B | 0.6% | 1.6% | 20.8% | 2.2% | 1.95 | 8.50 | 52.7% | — | 3.4% | 13.78 | +0.00% | 148K |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.4B | — | 13.2% | 18.1% | 15.7% | 3.48 | 0.15 | 75.4% | 24.0% | 18.9% | 41.85 | -2.39% | 72K |
| ZYME | Zymeworks Inc. | $2.1B | — | -37.8% | — | — | 6.32 | 3.94 | — | — | — | 29.89 | -3.70% | 26K |
| LBRX | LB PHARMACEUTICALS INC | $1.5B | — | -23.7% | -25.8% | -25.8% | 15.08 | 0.09 | — | — | — | 47.51 | -3.98% | 8K |
| ANRO | Alto Neuroscience, Inc. | $1.4B | — | -33.2% | -38.4% | -36.4% | 14.85 | 0.06 | — | — | — | 36.33 | -0.81% | 13K |
| EOLS | Evolus, Inc. | $598M | — | -13.8% | — | -27.3% | 1.70 | -5.07 | 66.7% | -5.9% | -10.8% | 9.06 | +0.06% | 42K |
| PBYI | PUMA BIOTECHNOLOGY, INC. | $485M | — | 13.9% | 19.3% | 19.3% | 2.91 | 0.00 | 74.8% | 13.2% | 11.6% | 9.39 | -3.20% | 12K |
| SGMT | Sagimet Biosciences Inc. | $468M | — | -17.9% | -18.4% | -18.4% | 45.02 | 0.03 | — | — | — | 10.90 | -0.91% | 57K |
| LEXX | Lexaria Bioscience Corp. | $305M | — | — | — | — | 10.60 | 0.09 | 27.5% | — | — | 12.31 | -7.44% | 764 |
| LGVN | Longeveron Inc. | $186M | — | — | — | — | 2.63 | 0.01 | 69.8% | — | — | 6.61 | -3.22% | 973 |
| VBIO | Valion Bio, Inc. | $62M | — | -57.7% | — | — | 1.11 | 4.85 | 0.3% | — | — | 2.80 | -10.26% | 174 |
| RMTI | ROCKWELL MEDICAL, INC. | $33M | — | -9.0% | -14.5% | — | 3.25 | 0.21 | 17.7% | -6.5% | -7.3% | 8.09 | +0.75% | 105 |
| BFRI | Biofrontera Inc. | $23M | — | -26.5% | — | — | 1.18 | 3.04 | — | -14.2% | -13.8% | 1.51 | +0.33% | 12K |
| ADIL | Adial Pharmaceuticals, Inc. | $17M | — | — | — | — | 5.63 | -0.75 | — | — | — | 6.36 | -0.31% | 312 |
| FTH | Faeth Therapeutics, Inc. | — | — | — | — | — | 19.69 | 0.00 | — | — | — | 40.27 | +2.82% | 21K |
| PRE | Prenetics Global Ltd | — | — | — | — | — | — | — | — | — | — | 25.66 | -1.17% | 9K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.